An important milestone in paediatric brain cancer research, with the world-first PaedNeoVax clinical trial now open at three Australian hospitals.

The Phase 1 trial will investigate the safety of experimental personalised mRNA vaccines for children with aggressive and treatment-resistant brain tumours.

The first four places have been allocated to eligible participants to begin screening for potential enrolment.

We're proud to be supporting this research and look forward to following its progress.

READ MORE HERE.